Timing and Immune Status after Cellular Therapies Predict Response to COVID-19 Vaccines

BACKGROUND Cellular therapies (allogeneic hematopoietic cell transplantation, allo-HCT, autologous hematopoietic cell transplantation, auto-HCT, and chimeric antigen receptor T cell therapy, CAR T) render patients severely immunocompromised for extended periods post-therapy. Emerging data suggest re...

Descripción completa

Detalles Bibliográficos
Autores principales: Tamari, Roni, Politikos, Ioannis, Knorr, David, Vardhana, Santosha, Young, Jennifer, Marcello, Leeann, Doddi, Sital, Devlin, Sean M, Ramanathan, Lakshmi, Pessin, Melissa S., Dunn, Erica, Palazzo, Meighan A., Bravo, Christina, Papanicolaou, Genovefa A., Kamboj, Mini, Perales, Miguel-Angel, Chung, David J., Shah, Gunjan L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology. Published by Elsevier Inc. 2021
Materias:
722.Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701592/
http://dx.doi.org/10.1182/blood-2021-151376

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701592/
http://dx.doi.org/10.1182/blood-2021-151376

Ejemplares similares